Identifying anticholinergic burden in clinical practice
Prescriber · 2021-03 · 32 (3) · 20-23
DOI: 10.1002/psb.1901 ↗At a glance
Journal article in Prescriber, published online on 2021-03-23. Written by Brian Bell and 1 co-authors. Cited 6 times so far (Crossref); 16 references.
Abstract (original language)
Anticholinergic medications are associated with a wide range of adverse effects to which elderly patients are particularly susceptible. This article discusses the various ways that anticholinergic burden can be measured, how these can be used to help clinicians identify patients at risk from the adverse effects of anticholinergics, and how to address these risks.
Cite
APA
Bell, B., & Avery, A. (2021). Identifying anticholinergic burden in clinical practice. Prescriber, 32(3), 20-23. https://doi.org/10.1002/psb.1901
Vancouver
Bell B, Avery A. Identifying anticholinergic burden in clinical practice. Prescriber. 2021;32(3):20-23. doi:10.1002/psb.1901
BibTeX
@article{Bell2021,
author = {Bell, Brian and Avery, Anthony},
title = {Identifying anticholinergic burden in clinical practice},
journal = {Prescriber},
year = {2021},
volume = {32},
number = {3},
pages = {20--23},
doi = {10.1002/psb.1901}
}
EUVIMED